Clinical trial
Counseling Interventions for BRCA 1/2 Cancer Susceptibility Testing
NCT00165152
Study timeline
Study start (unknown)1998-07-01Date precision: month
Registry last updated2012-08-09
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Breast Cancerunresolved
Ovarian Cancerunresolved
Interventions
Genetic CounselingPROCEDURE
Informed Consent CounselingPROCEDURE
Sponsors & collaborators
Dana-Farber Cancer Institutelead sponsor
Massachusetts General Hospitalcollaborator
Beth Israel Deaconess Medical Centercollaborator
Medical University of South Carolinacollaborator
National Cancer Institute (NCI)collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00165152 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.